Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03285607 |
Title | MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer |
Recruitment | Withdrawn |
Gender | |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Washington University School of Medicine |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries |
Facility | Status | City | State | Zip | Country | Details |
---|